Effect of Irbesartan on Chemerin in the Renal Tissues of Diabetic Rats
Background/Aims: Chemerin was introduced as a novel adipokine that plays a crucial role in insulin signaling and diabetic nephropathy. Serum chemerin levels are significantly elevated in type 2 diabetes patients with macroalbuminuria. However, the underlying mechanisms remain unclear. We conducted a...
| Published in: | Kidney & Blood Pressure Research |
|---|---|
| Main Authors: | Qiu-Xia Yu, Hong Zhang, Wen-Hui Xu, Fei Hao, Su-Lai Liu, Meng-Meng Bai, Jia-Wei Mu, Hui-Juan Zhang |
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2015-09-01
|
| Subjects: | |
| Online Access: | http://www.karger.com/Article/FullText/368523 |
Similar Items
Irbesartan attenuates renal injury with diabetic nephropathy rats
by: ZHANG Ya, HUANG Wen-hui, HOU Zhi-min, LIU Ju-xiang, LIU Jing
Published: (2020-04-01)
by: ZHANG Ya, HUANG Wen-hui, HOU Zhi-min, LIU Ju-xiang, LIU Jing
Published: (2020-04-01)
IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015-09-01)
by: V. I. Podzolkov, et al.
Published: (2015-09-01)
Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland
by: AJ Palmer, et al.
Published: (2006-05-01)
by: AJ Palmer, et al.
Published: (2006-05-01)
Clinical efficacy of benazepril and irbesartan for children with chronic glomerulonephritis
by: LIU Xiao-yan
Published: (2016-01-01)
by: LIU Xiao-yan
Published: (2016-01-01)
Determination of Irbesartan in Pharmaceutical Preparations by HPLC
by: Bilal Yılmaz
Published: (2025-06-01)
by: Bilal Yılmaz
Published: (2025-06-01)
Novel Role of Irbesartan in Elevating Serum High Density Lipoprotein in Hypercholesterolemic Animal Model
by: Sabeen Shakir, et al.
Published: (2024-05-01)
by: Sabeen Shakir, et al.
Published: (2024-05-01)
Angiotensin II receptor blockers and cardiorenal risk management: Irbesartan status
by: V. V. Fomin
Published: (2013-12-01)
by: V. V. Fomin
Published: (2013-12-01)
Rhabdomyolysis Induced by Irbesartan‐Hydrochlorothiazide in an Elderly Patient
by: Wei Yang, et al.
Published: (2025-10-01)
by: Wei Yang, et al.
Published: (2025-10-01)
Comparative bioavailability of a newly developed Irbesartan 300 mg containing preparation
by: Petrov Andrey D., et al.
Published: (2018-01-01)
by: Petrov Andrey D., et al.
Published: (2018-01-01)
Irbesartan; An Antihypertensive Drug Reduces LDL-Cholesterol in Diet Induced Hyperlipidemic Rabbits
by: Sabeen Shakir , Akbar Waheed , Noureen Hafeez
Published: (2016-09-01)
by: Sabeen Shakir , Akbar Waheed , Noureen Hafeez
Published: (2016-09-01)
Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis
by: Hongmei Yu, et al.
Published: (2024-10-01)
by: Hongmei Yu, et al.
Published: (2024-10-01)
Pharmacokinetic interaction between irbesartan and Orthosiphon stamineus extract in rat plasma
by: Nur Meilis, et al.
Published: (2016-02-01)
by: Nur Meilis, et al.
Published: (2016-02-01)
Active Forms of Chemerin Are Elevated in Human and Mouse Ovarian Carcinoma
by: Lei Zhao, et al.
Published: (2025-04-01)
by: Lei Zhao, et al.
Published: (2025-04-01)
Role of Chemerin in Cardiovascular Diseases
by: Mirjana T. Macvanin, et al.
Published: (2022-11-01)
by: Mirjana T. Macvanin, et al.
Published: (2022-11-01)
EXPERIMENTAL INVESTIGATION OF THE EFFECT ON THE CHEMERIN ADIPOKINE AND OBESITY OF PROBIOTIC USE IN OBESE RATS
by: Mensure Nur Celik, et al.
Published: (2017-06-01)
by: Mensure Nur Celik, et al.
Published: (2017-06-01)
A local renal renin–angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats
by: Tojo A, et al.
Published: (2016-01-01)
by: Tojo A, et al.
Published: (2016-01-01)
HPLC method with monolithic column for simultaneous determination of irbesartan and hydrochlorothiazide in tablets
by: Alanazi Amer M., et al.
Published: (2014-06-01)
by: Alanazi Amer M., et al.
Published: (2014-06-01)
Chemerin in Pulmonary Fibrosis: Advances in Mechanistic and Fundamental Research
by: Yongshuai Jiang, et al.
Published: (2025-10-01)
by: Yongshuai Jiang, et al.
Published: (2025-10-01)
Oral Formulation Based on Irbesartan Nanocrystals Improve Drug Solubility, Absorbability, and Efficacy
by: Noriaki Nagai, et al.
Published: (2022-02-01)
by: Noriaki Nagai, et al.
Published: (2022-02-01)
Chemerin Forms: Their Generation and Activity
by: Lei Zhao, et al.
Published: (2022-08-01)
by: Lei Zhao, et al.
Published: (2022-08-01)
Nanocrystalline Suspensions of Irbesartan Enhance Oral Bioavailability by Improving Drug Solubility and Leading Endocytosis Uptake into the Intestine
by: Saori Deguchi, et al.
Published: (2021-09-01)
by: Saori Deguchi, et al.
Published: (2021-09-01)
Study of influence of Catha edulis (Khat) chewing on oral pharmacokinetics of irbesartan in rats using a newly developed HPLC-UV method
by: Hassan A. Alhazmi, et al.
Published: (2022-03-01)
by: Hassan A. Alhazmi, et al.
Published: (2022-03-01)
Combined treatment of irbesartan and diltiazem ameliorates endothelium dependent vasodilatation in hypertensives
by: Tingting Zhou, et al.
Published: (2017-10-01)
by: Tingting Zhou, et al.
Published: (2017-10-01)
Seven New Irbesartan Salts: Significantly Improved Dissolution, Excellent Hygrothermal Stability, and Characteristic Supramolecular Synthons
by: Junxiao Wang, et al.
Published: (2025-04-01)
by: Junxiao Wang, et al.
Published: (2025-04-01)
Efficiency assessment for antihypertensive, hemodynamic, renal effects of adenosine-converting enzyme (ACE) inhibitors and irbesartan and impact on endothelial disfunction in patients with stage II hypertension
by: M. V. Pereviazkina
Published: (2014-08-01)
by: M. V. Pereviazkina
Published: (2014-08-01)
Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus
by: Yaoxian Liang, et al.
Published: (2015-03-01)
by: Yaoxian Liang, et al.
Published: (2015-03-01)
Is Chemerin Associated with Gestational Diabetes Mellitus? A Case-Control Study
by: Ma Z, et al.
Published: (2023-08-01)
by: Ma Z, et al.
Published: (2023-08-01)
Evaluation of Salivary Chemerin and Visfatin in Relation to Periodontitis and Obesity
by: Farah Razak Abood, et al.
Published: (2025-04-01)
by: Farah Razak Abood, et al.
Published: (2025-04-01)
Study of the Correlation between the Level of CRP and Chemerin of Serum and the Occurrence and Development of DN
by: Wang Yunqian, et al.
Published: (2015-01-01)
by: Wang Yunqian, et al.
Published: (2015-01-01)
Irbesartan ameliorates inflammation via transendothelial leukocyte migration due to VCAM-1/NOX-1 signaling in cisplatin-induced cardiotoxicity
by: Dilek Ulusoy Karatopuk, et al.
Published: (2023-11-01)
by: Dilek Ulusoy Karatopuk, et al.
Published: (2023-11-01)
Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito®) in Korean adults with hypertension and hypercholesterolemia
by: Ihm SH, et al.
Published: (2019-02-01)
by: Ihm SH, et al.
Published: (2019-02-01)
Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological Evidence
by: Bianca Domingues Massolini, et al.
Published: (2020-03-01)
by: Bianca Domingues Massolini, et al.
Published: (2020-03-01)
Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization
by: Narendar Dudhipala, et al.
Published: (2021-12-01)
by: Narendar Dudhipala, et al.
Published: (2021-12-01)
Studies on jackfruit seed starch as a novel natural superdisintegrant for the design and evaluation of irbesartan fast dissolving tablets
by: Vidyadhara Suryadevara, et al.
Published: (2017-09-01)
by: Vidyadhara Suryadevara, et al.
Published: (2017-09-01)
The Role of Chemerin in Neutrophil Activation and Diseases of the Lung
by: Patrick Arndt
Published: (2025-05-01)
by: Patrick Arndt
Published: (2025-05-01)
Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
by: Lin Zhang, et al.
Published: (2017-10-01)
by: Lin Zhang, et al.
Published: (2017-10-01)
Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype
by: Rui Sun, et al.
Published: (2022-10-01)
by: Rui Sun, et al.
Published: (2022-10-01)
Chemerin as Potential Biomarker in Pediatric Diseases: A PRISMA-Compliant Study
by: Katarzyna Zdanowicz, et al.
Published: (2022-03-01)
by: Katarzyna Zdanowicz, et al.
Published: (2022-03-01)
Effect of Irbesartan on TRPC6 expression in high glucose-induced mouse podocytes
by: HU Chun-li, et al.
Published: (2016-01-01)
by: HU Chun-li, et al.
Published: (2016-01-01)
Probiotics Improve Chemerin Levels and Metabolic Syndrome Parameters in Obese Rats
by: Menşure Nur Çelik, et al.
Published: (2019-09-01)
by: Menşure Nur Çelik, et al.
Published: (2019-09-01)
Similar Items
-
Irbesartan attenuates renal injury with diabetic nephropathy rats
by: ZHANG Ya, HUANG Wen-hui, HOU Zhi-min, LIU Ju-xiang, LIU Jing
Published: (2020-04-01) -
IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015-09-01) -
Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland
by: AJ Palmer, et al.
Published: (2006-05-01) -
Clinical efficacy of benazepril and irbesartan for children with chronic glomerulonephritis
by: LIU Xiao-yan
Published: (2016-01-01) -
Determination of Irbesartan in Pharmaceutical Preparations by HPLC
by: Bilal Yılmaz
Published: (2025-06-01)
